Nerve Repair & Regeneration Market
完整報告名稱與涵蓋範圍
Nerve Repair & Regeneration Market by Product (Neuromodulation devices, Conduit, Wrap, Protector, Grafts), Procedure (Nerve Repair [Epineural, Perineural], Grafting [Allograft, Xenograft]), Application, End User, No. of Devices – Global Forecast to 2031
報告摘要
The nerve repair & regeneration market is projected to grow from USD 8.06 billion in 2026 to USD 12.64 billion by 2031, at a CAGR of 9.42%. The increasing incidence of traumatic nerve injuries, peripheral nerve damage, and neurological disorders is driving demand for effective nerve repair and functional restoration solutions. As surgical and regenerative approaches continue to advance, the need for innovative nerve grafts, conduits, biomaterials, and neurostimulation technologies is expanding across hospitals and specialty care settings. Furthermore, advancements in tissue engineering, bioengineered scaffolds, nerve regeneration techniques, and minimally invasive procedures are improving treatment outcomes and supporting faster functional recovery. These innovations enable healthcare providers to address complex nerve injuries more effectively, supporting growth in the nerve repair & regeneration market.
“The Neurostimulation and Neuromodulation segment is expected to account for the largest share of the nerve repair and regeneration market, by procedure.”
Based on procedure, the nerve repair and regeneration market is segmented into neurostimulation & neuromodulation and nerve repair & regeneration. The neurostimulation & neuromodulation segment accounts for the largest market share because stimulation-based therapies are established for managing chronic pain, neurological disorders, and nerve-related conditions. These technologies provide targeted therapeutic interventions through electrical stimulation of nerves or neural pathways, supporting symptom management and improved patient outcomes. Additionally, the increasing adoption of implantable and non-invasive stimulation systems, growing availability of advanced neuromodulation technologies, and expanding clinical applications continue to support demand for these procedures, making neurostimulation and neuromodulation the largest segment within the market.
“The Hospitals and Ambulatory Surgical Centers segment is expected to account for the largest share of the nerve repair and regeneration market.”
The global nerve repair and regeneration market can be segmented by end user into hospitals and ambulatory surgical centers (ASCs), specialty clinics, and other end users. Among these, the hospitals and ASCs segment accounted for the largest market share. Hospitals and ASCs remain the primary settings for nerve repair, reconstructive procedures, and neurostimulation interventions due to the availability of specialized surgical teams, advanced operating facilities, and comprehensive postoperative care. Furthermore, the increasing adoption of specialized nerve treatment procedures, the availability of advanced surgical equipment, and the growing preference for outpatient interventions are expected to support continued use of nerve repair and regeneration solutions across hospitals and ASCs worldwide.
“Asia Pacific: The fastest-growing market for nerve repair and regeneration from 2026 to 2031”
The global nerve repair and regeneration market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest regional CAGR from 2026 to 2031. The region is witnessing increasing demand for advanced neurological and reconstructive procedures, supported by improvements in specialized healthcare services and surgical capabilities. China is expanding access to advanced medical technologies through healthcare infrastructure development and increasing investments in specialized neurological care. India's growing network of tertiary-care hospitals, specialty clinics, and surgical centers is supporting the adoption of nerve repair, regeneration, and neuromodulation technologies. Meanwhile, Japan's aging population and increasing demand for neurological and pain management therapies continue to support the expansion of the nerve repair and regeneration market across the region.
The breakdown of the profile of primary participants in the nerve repair and regeneration market:
• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level Executives - 27%, Directors – 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa - 4%
Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US) are among the key players operating in the nerve repair and regeneration market.
Research Coverage:
This research report categorizes the nerve repair and regeneration market by product (neurostimulation & neuromodulation, biomaterial-based products), by procedure (neurostimulation & neuromodulation and nerve repair & regeneration), by application (peripheral nerve injuries, spinal cord injuries, neuropathic pain, neurodegenerative disorders, cranial nerve disorders, urological & pelvic nerve disorders, orthopedic & sports-related nerve injuries and other applications), by end user (hospitals & ASCs, specialty clinics, other end users), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa).
The report covers detailed information on major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the nerve repair and regeneration market. A detailed analysis of key industry players provides insights into their business overview, solutions, key strategies such as acquisitions, agreements, and product launches, and recent developments in the nerve repair and regeneration market. This report covers a competitive analysis of upcoming startups in the nerve repair and regeneration market ecosystem.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall repair and regeneration market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (rising prevalence of neurological disorders and nerve injuries, rising geriatric population and the subsequent increase in the prevalence of neurological disorders, favorable government support and funding with advanced healthcare infrastructure, development of advanced neuromodulation and neurostimulation technologies), restraints (preference for drug therapies over neuromodulation products), opportunities (large patient population and rising healthcare investments in emerging economies, expanding clinical applications of nerve repair and regeneration technologies), and challenges (stringent regulatory framework and time-consuming approval processes for nerve repair and regeneration products, shortage of trained professionals) influencing the growth of the nerve repair and regeneration market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nerve repair and regeneration market
• Market Development: Comprehensive information about lucrative markets—the report analyzes the nerve repair and regeneration market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nerve repair and regeneration market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US)
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
TABLE 1 KEY MOVES & STRATEGIC FOCUS 60
TABLE 2 NERVE REPAIR & REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS 62
TABLE 3 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030 63
TABLE 4 NORTH AMERICA: MACROECONOMIC INDICATORS 64
TABLE 5 EUROPE: MACROECONOMIC INDICATORS 65
TABLE 6 ASIA PACIFIC: MACROECONOMIC INDICATORS 65
TABLE 7 LATIN AMERICA: MACROECONOMIC INDICATORS 65
TABLE 8 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 65
TABLE 9 NERVE REPAIR & REGENERATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM 68
TABLE 10 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024–2026 (USD) 69
TABLE 11 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024–2026 (USD) 70
TABLE 12 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 71
TABLE 13 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 72
TABLE 14 NERVE REPAIR & REGENERATION MARKET: KEY CONFERENCES & EVENTS,
2026–2027 72
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 77
TABLE 16 KEY PATENTS IN NERVE REPAIR & REGENERATION MARKET, 2022–2026 87
TABLE 17 KEY COMPANIES IMPLEMENTING AI IN NERVE REPAIR & REGENERATION MARKET 91
TABLE 18 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 93
TABLE 19 NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) MEDICAL DEVICES CLASSIFICATION 94
TABLE 20 JAPAN: CLASSIFICATION OF MEDICAL DEVICES 95
TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 101
TABLE 27 KEY BUYING CRITERIA, BY END USER 101
TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES 102
TABLE 29 NERVE REPAIR & REGENERATION MARKET: UNMET NEEDS IN
VARIOUS END-USE INDUSTRIES 104
TABLE 30 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 108
TABLE 31 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 109
TABLE 32 SPINAL CORD STIMULATION DEVICES OFFERED BY KEY PLAYERS 110
TABLE 33 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 110
TABLE 34 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 35 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 36 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 37 DEEP BRAIN STIMULATION DEVICES OFFERED BY KEY PLAYERS 112
TABLE 38 NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 112
TABLE 39 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 40 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 41 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 42 VAGUS NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS 114
TABLE 43 NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 114
TABLE 44 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 115
TABLE 45 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 115
TABLE 46 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 115
TABLE 47 SACRAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS 116
TABLE 48 NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 116
TABLE 49 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 50 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 51 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 52 GASTRIC NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS 118
TABLE 53 NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 118
TABLE 54 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 55 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 56 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 57 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES OFFERED
BY KEY PLAYERS 120
TABLE 58 NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 121
TABLE 59 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 60 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY,
2024–2031 (USD MILLION) 121
TABLE 61 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY,
2024–2031 (USD MILLION) 122
TABLE 62 TRANSCRANIAL MAGNETIC STIMULATION DEVICES OFFERED BY KEY PLAYERS 122
TABLE 63 NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 123
TABLE 64 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 65 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 66 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 67 RESPIRATORY ELECTRICAL STIMULATION DEVICES OFFERED BY KEY PLAYERS 124
TABLE 68 NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION) 125
TABLE 69 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 70 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 71 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 72 OTHER STIMULATION DEVICES OFFERED BY KEY PLAYERS 127
TABLE 73 NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES,
BY REGION, 2024–2031 (USD MILLION) 127
TABLE 74 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 75 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 76 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 77 NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE,
2024–2031 (USD MILLION) 129
TABLE 78 NERVE CONDUITS OFFERED BY SOME MARKET PLAYERS 130
TABLE 79 NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY REGION, 2024–2031 (USD MILLION) 130
TABLE 80 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 81 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS,
BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 82 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 83 NERVE GRAFTS OFFERED BY SOME MARKET PLAYERS 132
TABLE 84 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY REGION, 2024–2031 (USD MILLION) 132
TABLE 85 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 86 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS,
BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 87 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS,
BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 88 NERVE WRAPS OFFERED BY SOME MARKET PLAYERS 134
TABLE 89 NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY REGION, 2024–2031 (USD MILLION) 134
TABLE 90 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 91 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS,
BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 92 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS,
BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 93 NERVE PROTECTORS OFFERED BY SOME MARKET PLAYERS 136
TABLE 94 NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY REGION, 2024–2031 (USD MILLION) 136
TABLE 95 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 96 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS,
BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 97 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 98 GLOBAL NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (NUMBER OF DEVICES) 138
TABLE 99 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 140
TABLE 100 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 101 NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 141
TABLE 102 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 141
TABLE 103 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 142
TABLE 104 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 142
TABLE 105 NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 143
TABLE 106 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 107 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 108 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 109 NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 145
TABLE 110 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 146
TABLE 111 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 146
TABLE 112 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 113 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 114 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 115 NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 148
TABLE 116 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 117 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 118 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 119 NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 149
TABLE 120 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 121 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 122 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 123 NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 151
TABLE 124 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 125 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 126 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 127 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 153
TABLE 128 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 153
TABLE 129 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 130 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 131 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 132 NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY REGION,
2024–2031 (USD MILLION) 155
TABLE 133 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 134 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS,
BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 135 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS,
BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 136 NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY REGION,
2024–2031 (USD MILLION) 156
TABLE 137 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 138 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS,
BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 139 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS,
BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 140 NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY REGION, 2024–2031 (USD MILLION) 158
TABLE 141 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 142 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 143 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 144 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 161
TABLE 145 NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES,
BY REGION, 2024–2031 (USD MILLION) 162
TABLE 146 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 147 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 148 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 149 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES,
BY REGION, 2024–2031 (USD MILLION) 164
TABLE 150 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, 2024–2031 (USD MILLION) 164
TABLE 151 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 152 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 153 NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY REGION, 2024–2031 (USD MILLION) 166
TABLE 154 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 155 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 156 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 157 NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY REGION, 2024–2031 (USD MILLION) 168
TABLE 158 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, 2024–2031 (USD MILLION) 169
TABLE 159 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 160 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 161 NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS,
BY REGION, 2024–2031 (USD MILLION) 170
TABLE 162 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, 2024–2031 (USD MILLION) 170
TABLE 163 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 164 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 165 NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY REGION, 2024–2031 (USD MILLION) 172
TABLE 166 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, 2024–2031 (USD MILLION) 172
TABLE 167 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 168 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 169 NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY REGION, 2024–2031 (USD MILLION) 174
TABLE 170 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, 2024–2031 (USD MILLION) 174
TABLE 171 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 172 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 173 NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 176
TABLE 174 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, 2024–2031 (USD MILLION) 176
TABLE 175 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 176 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 177 NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 179
TABLE 178 NUMBER OF HOSPITALS PER CAPITA, BY COUNTRY, 2026 180
TABLE 179 NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2024–2031 (USD MILLION) 180
TABLE 180 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 181 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 182 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 183 NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY REGION, 2024–2031 (USD MILLION) 182
TABLE 184 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 185 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS,
BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 186 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 187 NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 184
TABLE 188 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR
OTHER END USERS, 2024–2031 (USD MILLION) 184
TABLE 189 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 190 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 191 NERVE REPAIR & REGENERATION MARKET, BY REGION,
2024–2031 (USD MILLION) 187
TABLE 192 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 193 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 189
TABLE 194 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE,
2024–2031 (USD MILLION) 190
TABLE 195 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 190
TABLE 196 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION) 191
TABLE 197 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 191
TABLE 198 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 191
TABLE 199 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 200 NORTH AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 201 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193
TABLE 202 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION) 193
TABLE 203 COMPANY PRODUCTS THAT RECEIVED APPROVAL IN US 195
TABLE 204 US: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 195
TABLE 205 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 206 US: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 207 US: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 197
TABLE 208 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 209 US: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 210 US: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 211 US: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 212 US: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 199
TABLE 213 US: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 199
圖表清單 List of Tables & Figures
TABLE 214 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 200
TABLE 215 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 216 CANADA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 217 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 202
TABLE 218 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 219 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 220 CANADA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 221 CANADA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 222 CANADA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 204
TABLE 223 CANADA: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 204
TABLE 224 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 205
TABLE 225 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 206
TABLE 226 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 227 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 228 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 207
TABLE 229 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 230 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 231 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 232 EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 233 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 209
TABLE 234 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 209
TABLE 235 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 210
TABLE 236 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 237 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS,
BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 238 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 212
TABLE 239 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 240 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 241 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 242 GERMANY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 243 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 214
TABLE 244 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 214
TABLE 245 UK: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 215
TABLE 246 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 247 UK: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 248 UK: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 217
TABLE 249 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 250 UK: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 251 UK: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 252 UK: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 253 UK: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 219
TABLE 254 UK: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 219
TABLE 255 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 220
TABLE 256 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 257 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 258 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 222
TABLE 259 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 260 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 261 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 262 FRANCE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 263 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 224
TABLE 264 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 224
TABLE 265 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 225
TABLE 266 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 267 ITALY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 268 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 227
TABLE 269 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 270 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 271 ITALY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 272 ITALY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 273 ITALY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 229
TABLE 274 ITALY: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 229
TABLE 275 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 230
TABLE 276 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 277 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 278 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 232
TABLE 279 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 280 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 281 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 282 SPAIN: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 283 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 234
TABLE 284 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 285 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 235
TABLE 286 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 287 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 288 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION) 237
TABLE 289 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 290 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 291 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 292 REST OF EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 293 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 239
TABLE 294 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION) 239
TABLE 295 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 241
TABLE 296 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 241
TABLE 297 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 298 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS,
BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 299 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 243
TABLE 300 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 301 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 302 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 303 ASIA PACIFIC: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 304 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 245
TABLE 305 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 245
TABLE 306 CHINA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 246
TABLE 307 CHINA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 308 CHINA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 309 CHINA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 248
TABLE 310 CHINA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 311 CHINA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 312 CHINA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 313 CHINA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 314 CHINA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 250
TABLE 315 CHINA: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 250
TABLE 316 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 251
TABLE 317 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 318 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 319 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 253
TABLE 320 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 321 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 322 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 323 JAPAN: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 324 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 255
TABLE 325 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 255
TABLE 326 INDIA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 256
TABLE 327 INDIA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 328 INDIA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 329 INDIA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE,
2024–2031 (USD MILLION) 258
TABLE 330 INDIA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 331 INDIA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 332 INDIA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 333 INDIA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 334 INDIA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 260
TABLE 335 INDIA: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 260
TABLE 336 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 261
TABLE 337 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 338 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 339 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET,
BY PROCEDURE, 2024–2031 (USD MILLION) 263
TABLE 340 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 341 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 342 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 343 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 344 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 265
TABLE 345 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION) 265
TABLE 346 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 266
TABLE 347 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 348 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 349 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION) 268
TABLE 350 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 351 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 352 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 353 LATIN AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 354 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 270
TABLE 355 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER,
2024–2031 (USD MILLION) 270
TABLE 356 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 271
TABLE 357 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE,
2024–2031 (USD MILLION) 272
TABLE 358 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 359 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET,
BY PROCEDURE, 2024–2031 (USD MILLION) 273
TABLE 360 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 273
TABLE 361 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 362 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 363 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 364 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 275
TABLE 365 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET,
BY END USER, 2024–2031 (USD MILLION) 275
TABLE 366 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN NERVE REPAIR & REGENERATION MARKET, JANUARY 2023–AUGUST 2026 276
TABLE 367 NERVE REPAIR & REGENERATION MARKET: DEGREE OF COMPETITION 279
TABLE 368 NERVE REPAIR & REGENERATION MARKET: REGION FOOTPRINT 284
TABLE 369 NERVE REPAIR & REGENERATION MARKET: PRODUCT FOOTPRINT 285
TABLE 370 NERVE REPAIR & REGENERATION MARKET: PROCESS FOOTPRINT 285
TABLE 371 NERVE REPAIR & REGENERATION MARKET: END-USER FOOTPRINT 286
TABLE 372 NERVE REPAIR & REGENERATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 289
TABLE 373 NERVE REPAIR & REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 289
TABLE 374 NERVE REPAIR & REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 290
TABLE 375 NERVE REPAIR & REGENERATION MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023– AUGUST 2026 293
TABLE 376 NERVE REPAIR & REGENERATION MARKET: DEALS, JANUARY 2023–JULY 2026 294
TABLE 377 MEDTRONIC: COMPANY OVERVIEW 295
TABLE 378 MEDTRONIC: PRODUCTS OFFERED 296
TABLE 379 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2023–AUGUST 2026 297
TABLE 380 MEDTRONIC: DEALS, JANUARY 2023–AUGUST 2026 298
TABLE 381 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 299
TABLE 382 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 300
TABLE 383 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2023–AUGUST 2026 301
TABLE 384 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–AUGUST 2026 301
TABLE 385 ABBOTT: COMPANY OVERVIEW 303
TABLE 386 ABBOTT: PRODUCTS OFFERED 304
TABLE 387 ABBOTT: PRODUCT APPROVALS, JANUARY 2023–AUGUST 2026 305
TABLE 388 LIVANOVA PLC: COMPANY OVERVIEW 306
TABLE 389 LIVANOVA PLC: PRODUCTS OFFERED 307
TABLE 390 LIVANOVA PLC: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026 308
TABLE 391 AXOGEN CORPORATION: COMPANY OVERVIEW 309
TABLE 392 AXOGEN CORPORATION: PRODUCTS OFFERED 310
TABLE 393 AXOGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026 310
TABLE 394 NEUROPACE, INC.: COMPANY OVERVIEW 312
TABLE 395 NEUROPACE, INC.: PRODUCTS OFFERED 313
TABLE 396 BIOVENTUS: COMPANY OVERVIEW 314
TABLE 397 BIOVENTUS: PRODUCTS OFFERED 315
TABLE 398 BIOVENTUS: PRODUCT APPROVALS, JANUARY 2023–AUGUST 2026 316
TABLE 399 BAXTER: COMPANY OVERVIEW 317
TABLE 400 BAXTER: PRODUCTS OFFERED 318
TABLE 401 BAXTER: DEALS, JANUARY 2023–AUGUST 2026 319
TABLE 402 NEURONETICS: COMPANY OVERVIEW 320
TABLE 403 NEURONETICS: PRODUCTS OFFERED 321
TABLE 404 NEURONETICS: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–AUGUST 2026 322
TABLE 405 NEURONETICS: DEALS, JANUARY 2023–AUGUST 2026 322
TABLE 406 INTEGRA LIFESCIENCES: COMPANY OVERVIEW 323
TABLE 407 INTEGRA LIFESCIENCES: PRODUCTS OFFERED 324
TABLE 408 ELECTROCORE, INC.: COMPANY OVERVIEW 325
TABLE 409 ELECTROCORE, INC.: PRODUCTS OFFERED 326
TABLE 410 ELECTROCORE, INC.: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026 327
TABLE 411 ELECTROCORE, INC.: DEALS, JANUARY 2023–AUGUST 2026 327
TABLE 412 NEUROSIGMA, INC.: COMPANY OVERVIEW 328
TABLE 413 SOTERIX MEDICAL INC.: COMPANY OVERVIEW 329
TABLE 414 SYNAPSE BIOMEDICAL INC.: COMPANY OVERVIEW 330
TABLE 415 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW 331
TABLE 416 THERANICA BIO-ELECTRONICS LTD.: COMPANY OVERVIEW 332
TABLE 417 GIMER MEDICAL: COMPANY OVERVIEW 333
TABLE 418 REGENITY BIOSCIENCES: COMPANY OVERVIEW 334
TABLE 419 CHECKPOINT SURGICAL, INC.: COMPANY OVERVIEW 335
TABLE 420 RENISHAW PLC: COMPANY OVERVIEW 336
TABLE 421 TVNS TECHNOLOGIES GMBH: COMPANY OVERVIEW 337
TABLE 422 BIOWAVE: COMPANY OVERVIEW 338
TABLE 423 BIOTRONIK: COMPANY OVERVIEW 339
TABLE 424 SALUDA MEDICAL PTY LTD.: COMPANY OVERVIEW 340
TABLE 425 ALAFAIR BIOSCIENCES, INC.: COMPANY OVERVIEW 340
TABLE 426 NERVE REPAIR & REGENERATIVE MARKET: RISK ASSESSMENT 352
FIGURE 1 NERVE REPAIR & REGENERATION MARKET SEGMENTATION & REGIONAL SCOPE 37
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 41
FIGURE 3 GLOBAL NERVE REPAIR & REGENERATION MARKET, 2024–2031 42
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023–2025 42
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF NERVE REPAIR &
REGENERATION MARKET 43
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN NERVE REPAIR & REGENERATION MARKET, 2025 44
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 45
FIGURE 8 RISING CASES OF NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 46
FIGURE 9 NEUROSTIMULATION & NEUROMODULATION DEVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 47
FIGURE 10 NEUROSTIMULATION & NEUROMODULATION PROCEDURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 47
FIGURE 11 PERIPHERAL NERVE INJURIES SEGMENT TO LEAD MARKET DURING
FORECAST PERIOD 48
FIGURE 12 HOSPITALS & ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 48
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 49
FIGURE 14 NERVE REPAIR & REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 15 NERVE REPAIR & REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS 61
FIGURE 16 NERVE REPAIR & REGENERATION MARKET: SUPPLY CHAIN ANALYSIS 66
FIGURE 17 NERVE REPAIR & REGENERATION MARKET: VALUE CHAIN ANALYSIS 67
FIGURE 18 NERVE REPAIR & REGENERATION MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 19 NERVE REPAIR & REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN NERVE REPAIR &
REGENERATION MARKET 74
FIGURE 21 PATENT ANALYSIS FOR NERVE REPAIR & REGENERATION,
JANUARY 2016–DECEMBER 2025 86
FIGURE 22 MARKET POTENTIAL OF AI IN NERVE REPAIR & REGENERATION MARKET 90
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 100
FIGURE 24 KEY BUYING CRITERIA, BY END USER 101
FIGURE 25 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET SNAPSHOT 188
FIGURE 26 NUMBER OF PATIENTS WITH ALZHEIMER’S IN US, 2020–2060 (MILLION) 194
FIGURE 27 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET SNAPSHOT 240
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023–2025 (USD MILLION) 278
FIGURE 29 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (GLOBAL) 279
FIGURE 30 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (US) 281
FIGURE 31 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 283
FIGURE 32 NERVE REPAIR & REGENERATION MARKET: COMPANY FOOTPRINT 284
FIGURE 33 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2025 288
FIGURE 34 EV/EBITDA OF KEY VENDORS 290
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 291
FIGURE 36 NERVE REPAIR & REGENERATION MARKET: BRAND/PRODUCT COMPARISON FOR NERVE REPAIR & REGENERATION 292
FIGURE 37 MEDTRONIC: COMPANY SNAPSHOT (2025) 296
FIGURE 38 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 300
FIGURE 39 ABBOTT: COMPANY SNAPSHOT (2025) 304
FIGURE 40 LIVANOVA PLC: COMPANY SNAPSHOT (2025) 307
FIGURE 41 AXOGEN CORPORATION: COMPANY SNAPSHOT (2025) 309
FIGURE 42 NEUROPACE, INC.: COMPANY SNAPSHOT 312
FIGURE 43 BIOVENTUS: COMPANY SNAPSHOT (2025) 315
FIGURE 44 BAXTER: COMPANY SNAPSHOT (2025) 318
FIGURE 45 NEURONETICS: COMPANY SNAPSHOT (2025) 321
FIGURE 46 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2025) 324
FIGURE 47 ELECTROCORE, INC.: COMPANY SNAPSHOT (2024) 326
FIGURE 48 RESEARCH DESIGN 341
FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 346
FIGURE 50 TOP-DOWN APPROACH 349
FIGURE 51 DATA TRIANGULATION 350
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們